42 false false false false true true false false false false false false true false false false false false false 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 5,116,562 4,712,811 11,473,155 11,473,155 11,473,155 2,069,905 509,931 2,579,836 xbrli:pure xbrli:shares iso4217:GBP NI025270 2024-01-01 2024-12-31 NI025270 2024-12-31 NI025270 2023-12-31 NI025270 2023-01-01 2023-12-31 NI025270 2023-12-31 NI025270 2022-12-31 NI025270 core:Subsidiary1 2024-01-01 2024-12-31 NI025270 core:FurnitureFittings 2024-01-01 2024-12-31 NI025270 core:MotorVehicles 2024-01-01 2024-12-31 NI025270 bus:RegisteredOffice 2024-01-01 2024-12-31 NI025270 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 NI025270 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 NI025270 bus:Director1 2024-01-01 2024-12-31 NI025270 bus:Director2 2024-01-01 2024-12-31 NI025270 bus:Director3 2024-01-01 2024-12-31 NI025270 bus:Director4 2024-01-01 2024-12-31 NI025270 bus:Director5 2024-01-01 2024-12-31 NI025270 bus:CompanySecretary1 2024-01-01 2024-12-31 NI025270 core:WithinOneYear 2024-12-31 NI025270 core:WithinOneYear 2023-12-31 NI025270 core:LandBuildings core:OwnedOrFreeholdAssets 2023-12-31 NI025270 core:PlantMachinery 2023-12-31 NI025270 core:FurnitureFittings 2023-12-31 NI025270 core:MotorVehicles 2023-12-31 NI025270 core:LandBuildings core:OwnedOrFreeholdAssets 2024-12-31 NI025270 core:PlantMachinery 2024-12-31 NI025270 core:FurnitureFittings 2024-12-31 NI025270 core:MotorVehicles 2024-12-31 NI025270 core:DeferredTaxation 2024-01-01 2024-12-31 NI025270 core:LandBuildings core:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 NI025270 core:PlantMachinery 2024-01-01 2024-12-31 NI025270 core:AfterOneYear 2023-12-31 NI025270 core:UKTax 2024-01-01 2024-12-31 NI025270 core:UKTax 2023-01-01 2023-12-31 NI025270 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 NI025270 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 NI025270 bus:AllOrdinaryShares 2024-01-01 2024-12-31 NI025270 bus:AllOrdinaryShares 2023-01-01 2023-12-31 NI025270 core:RetainedEarningsAccumulatedLosses 2023-12-31 NI025270 core:RetainedEarningsAccumulatedLosses 2022-12-31 NI025270 core:RetainedEarningsAccumulatedLosses 2024-12-31 NI025270 core:RetainedEarningsAccumulatedLosses 2023-12-31 NI025270 core:ShareCapital 2024-12-31 NI025270 core:ShareCapital 2023-12-31 NI025270 core:CapitalRedemptionReserve 2024-12-31 NI025270 core:CapitalRedemptionReserve 2023-12-31 NI025270 core:BetweenOneFiveYears 2024-12-31 NI025270 core:BetweenOneFiveYears 2023-12-31 NI025270 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 NI025270 core:Non-currentFinancialInstruments 2024-12-31 NI025270 core:Non-currentFinancialInstruments 2023-12-31 NI025270 core:AcceleratedTaxDepreciationDeferredTax 2024-12-31 NI025270 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 NI025270 core:LandBuildings core:OwnedOrFreeholdAssets 2023-12-31 NI025270 core:PlantMachinery 2023-12-31 NI025270 core:FurnitureFittings 2023-12-31 NI025270 core:MotorVehicles 2023-12-31 NI025270 core:DeferredTaxation 2023-12-31 NI025270 core:DeferredTaxation 2024-12-31 NI025270 bus:LeadAgentIfApplicable 2023-01-01 2023-12-31 NI025270 bus:HighestPaidDirector 2024-01-01 2024-12-31 NI025270 bus:HighestPaidDirector 2023-01-01 2023-12-31 NI025270 bus:MediumEntities 2024-01-01 2024-12-31 NI025270 bus:Audited 2024-01-01 2024-12-31 NI025270 bus:Medium-sizedCompaniesRegimeForAccounts 2024-01-01 2024-12-31 NI025270 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 NI025270 bus:FullAccounts 2024-01-01 2024-12-31 NI025270 bus:OrdinaryShareClass1 2024-12-31 NI025270 bus:OrdinaryShareClass1 2023-12-31 NI025270 1 2024-01-01 2024-12-31 NI025270 core:PlantMachinery core:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 NI025270 core:CapitalRedemptionReserve 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: NI025270

Conexpo (NI) Limited

Financial Statements

31 December 2024

Conexpo (NI) Limited

Financial Statements

Year ended 31 December 2024

Contents | Page

Officers and professional advisers | 1

Strategic report | 2

Directors' report | 4

Independent auditor's report to the members | 6

Statement of income and retained earnings | 11

Statement of financial position | 12

Statement of cash flows | 13

Notes to the financial statements | 14

Conexpo (NI) Limited

Officers and Professional Advisers

The board of directors | Mr R McCluskey
| Mrs B McCluskey
| Mr J McCluskey
| Mr S McCluskey
| Mr J Hilland

Company secretary | Mr S McCluskey

Registered office | Aisling House
| 50 Stranmillis Embankment
| Belfast
| BT9 5FL

Auditor | Maneely Mc Cann Chartered Accountants
| Chartered accountants & statutory auditor
| Aisling House
| 50 Stranmillis Embankment
| Belfast
| BT9 5FL

Bankers | Danske Bank
| Donegall Square West
| Belfast
| BT1 6JS

Solicitors | Hewitt & Gilpin Solicitors
| Thomas House
| 14 -16 James Street South
| Belfast
| BT2 7GA

Conexpo (NI) Limited

Strategic Report

Year ended 31 December 2024
The directors present the strategic report for the year ended 31 December 2024. Fair review of the business We aim to present a balanced review of the development and performance of the business during the year and its position at the year end. Our review is consistent with the size and non-complex nature of the business and is written within the context of the risks and uncertainties that we face. The principal activity of the company continued to be that of the production, sourcing and marketing of construction aggregates. No material changes are anticipated in the foreseeable future. The main area of the business is the provision of aggregates for road repair and maintenance purposes, mainly in Great Britain but also markets have been secured on the western periphery of mainland Europe. Principal risks and uncertainties Over the last year the market for road repair and maintenance in the UK and mainland Europe has remained challenging due to the level of government funding available. Indeed the business environment in which the group operate continues to be challenging as the level of public funding available for road repair and maintenance has a significant impact on the business. Development and performance The Directors are of the opinion that trading performance was satisfactory in 2024. Looking ahead the directors anticipate a steady performance in 2025 despite the political and economic uncertainties which remain over the Northern Ireland and UK economies. Whilst the ongoing impact of Brexit remains uncertain, the company has actively managed this risk and with the key market for product being within the UK, there has been minimal impact or disruption on activities. Over recent years the company has invested in both quarry reserves and new production facilities to expand and strengthen production capability and strengthen and secure continuity of product supply to its customer base. Investment made in 2024 will further enhance trading, profitability and cash generation going forward and future profits will be used to both underpin the existing strong liquidity of the business and further strengthen the company's financial position through the reduction of net debt. Key performance indicators We consider that our key performance indicators are those that communicate the financial performance and strength of the group as a whole, these being turnover, gross profit and gross margin.

|  | 2024 | 2023 | 2022
|  | £ | £ | £
| Turnover | 38,907,620 | 36,623,885 | 32,321,067
| Gross Profit | 7,467,437 | 6,436,141 | 4,257,320
| Gross Margin % | 19 | 18 | 13

The results for the year and the financial position at the year end were considered satisfactory by the directors.
This report was approved by the board of directors on 7 April 2025 and signed on behalf of the board by:

Mr J Hilland
Director

Registered office:
Aisling House
50 Stranmillis Embankment
Belfast
BT9 5FL

Conexpo (NI) Limited

Directors' Report

Year ended 31 December 2024
The directors present their report and the financial statements of the company for the year ended 31 December 2024 .
Directors
The directors who served the company during the year were as follows:

Mr R McCluskey |
Mrs B McCluskey |
Mr J McCluskey |
Mr S McCluskey |
Mr J Hilland |

Dividends
Particulars of recommended dividends are detailed in note 13 to the financial statements.
Future developments
The directors are keen to expand production and increase efficiency through innovative means in the year ahead. The directors believe this is imperative to continue to meet customer demands. Looking ahead, the group would like to further develop its European market, however is realistic about the challenges that exist surrounding the uncertainties of Brexit.
Research and development
Conexpo continues to develop a new crushing and processing facility. This facility will pioneer the production of various aggregate types simultaneously. Different plant manufacturers and engineers have been brought together to research and develop this new method of producing aggregate.
Directors' responsibilities statement
The directors are responsible for preparing the strategic report, directors' report and the financial statements in accordance with applicable law and regulations. Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: - select suitable accounting policies and then apply them consistently; - make judgments and accounting estimates that are reasonable and prudent; - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Auditor
Each of the persons who is a director at the date of approval of this report confirms that:
- so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.
This report was approved by the board of directors on 7 April 2025 and signed on behalf of the board by:

Mr J Hilland
Director

Registered office:
Aisling House
50 Stranmillis Embankment
Belfast
BT9 5FL

Conexpo (NI) Limited

Independent Auditor's Report to the Members of Conexpo (NI) Limited

Year ended 31 December 2024
Opinion
We have audited the financial statements of Conexpo (NI) Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of income and retained earnings, statement of financial position, statement of cash flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion the financial statements: - give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; - have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Identifying and assessing potential risks related to irregularities In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following: - the nature of the industry and sector, control environment and business performance including the design of the Group's remuneration policies, key drivers for directors' remuneration, bonus levels and performance targets; - results of our enquiries of management about their own identification and assessment of the risks of irregularities; - any matters we identified having obtained and reviewed the Group's documentation of their policies and procedures relating to: - identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance; - detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud; - the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations; - the matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. We also obtained an understanding of the legal and regulatory frameworks that the Group operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the Companies Act 2006 and Taxation Legislation. Audit response to risks identified Our procedures to respond to risks identified included the following: - reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements; - enquiring of management and external legal counsel concerning actual and potential litigation and claims; - performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud; - reading minutes of meetings of those charged with governance and reviewing correspondence with HMRC; and - in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in new making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business. We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit. As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also: - Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. - Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the internal control. - Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors. - Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern. - Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. Use of our report
This report is made solely to the company's members, as a body, in accordance with chapter 3 of part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Cathal Maneely
(Senior Statutory Auditor)

For and on behalf of
Maneely Mc Cann Chartered Accountants
Chartered accountants & statutory auditor
Aisling House
50 Stranmillis Embankment
Belfast
BT9 5FL

7 April 2025

Conexpo (NI) Limited

Statement of Income and Retained Earnings

Year ended 31 December 2024

| 2024 | 2023
Note | £ | £
Turnover | 4 | 38,907,620 | 36,623,885

Cost of sales | 31,440,183 | 30,187,744
| ------------- | -------------
Gross profit | 7,467,437 | 6,436,141

Administrative expenses | 1,105,589 | 952,483
Other operating income | 5 | 419,924 | 430,330
|  | ------------ | ------------
Operating profit | 6 | 6,781,772 | 5,913,988

Other interest receivable and similar income | 10 | 234,277 | 178,421
Interest payable and similar expenses | 11 | 26,737 | 304,875
| ------------ | ------------
Profit before taxation | 6,989,312 | 5,787,534

Tax on profit | 12 | 1,872,750 | 1,074,723
| ------------ | ------------
Profit for the financial year and total comprehensive income | 5,116,562 | 4,712,811
| ------------ | ------------

Dividends paid and payable | 13 | ( 1,868,807) | ( 999,963)

Retained earnings at the start of the year | 25,383,626 | 21,670,778
| ------------- | -------------
Retained earnings at the end of the year | 28,631,381 | 25,383,626
| ------------- | -------------

All the activities of the company are from continuing operations.

Conexpo (NI) Limited

Statement of Financial Position

31 December 2024

| 2024 | 2023
Note | £ | £

Fixed assets

Tangible assets | 14 | 16,829,827 | 16,190,563
Investments | 15 | 11,473,155 | 11,473,155
| ------------- | -------------
| 28,302,982 | 27,663,718

Current assets

Stocks | 16 | 1,051,630 | 961,669
Debtors | 17 | 3,297,785 | 5,155,738
Cash at bank and in hand | 8,408,982 | 6,256,519
| ------------- | -------------
| 12,758,397 | 12,373,926

Creditors: amounts falling due within one year | 18 | 9,770,159 | 11,303,706
| ------------- | -------------
Net current assets | 2,988,238 | 1,070,220
| ------------- | -------------
Total assets less current liabilities | 31,291,220 | 28,733,938

Creditors: amounts falling due after more than one year | 19 | – | 1,200,404

Provisions | 20 | 2,579,836 | 2,069,905
| ------------- | -------------
Net assets | 28,711,384 | 25,463,629
| ------------- | -------------

Capital and reserves

Called up share capital | 24 | 66,670 | 66,670
Capital redemption reserve | 25 | 13,333 | 13,333
Profit and loss account | 25 | 28,631,381 | 25,383,626
| ------------- | -------------
Shareholders funds | 28,711,384 | 25,463,629
| ------------- | -------------

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the medium companies regime.
These financial statements were approved by the board of directors and authorised for issue on 7 April 2025 , and are signed on behalf of the board by:

Mr J Hilland
Director

Company registration number: NI025270

Conexpo (NI) Limited

Statement of Cash Flows

Year ended 31 December 2024

| 2024 | 2023
| £ | £

Cash flows from operating activities

Profit for the financial year | 5,116,562 | 4,712,811

Adjustments for: |  |
Depreciation of tangible assets | 847,636 | 767,549
Government grant income | ( 1,418) | ( 1,294)
Other interest receivable and similar income | ( 234,277) | ( 178,421)
Interest payable and similar expenses | 26,737 | 304,875
Gains on disposal of tangible assets | ( 56,000) | ( 2,093)
Tax on profit | 1,872,750 | 1,074,723
Accrued expenses | 23,662 | 10,200

Changes in: |  |
Stocks | ( 89,961) | 111,947
Trade and other debtors | 1,857,953 | ( 951,001)
Trade and other creditors | ( 989,023) | 1,283,920
| ------------ | ------------
Cash generated from operations | 8,374,621 | 7,133,216

Interest paid | ( 26,737) | ( 304,875)
Interest received | 234,277 | 178,421
Tax paid | ( 1,396,738) | ( 793,543)
| ------------ | ------------
Net cash from operating activities | 7,185,423 | 6,213,219
| ------------ | ------------

Cash flows from investing activities

Purchase of tangible assets | ( 1,486,900) | ( 1,043,612)
Proceeds from sale of tangible assets | 56,000 | 78,082
| ------------ | ------------
Net cash used in investing activities | ( 1,430,900) | ( 965,530)
| ------------ | ------------

Cash flows from financing activities

Proceeds from borrowings | ( 1,284,399) | ( 4,108,528)
Proceeds from loans from group undertakings | ( 450,272) | 97,075
Government grant income | 1,418 | 1,294
Dividends paid | ( 1,868,807) | ( 999,963)
| ------------ | ------------
Net cash used in financing activities | ( 3,602,060) | ( 5,010,122)
| ------------ | ------------

Net increase in cash and cash equivalents | 2,152,463 | 237,567
Cash and cash equivalents at beginning of year | 6,256,519 | 6,018,952
| ------------ | ------------
Cash and cash equivalents at end of year | 8,408,982 | 6,256,519
| ------------ | ------------

Conexpo (NI) Limited

Notes to the Financial Statements

Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is Aisling House, 50 Stranmillis Embankment, Belfast, BT9 5FL.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Research expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial, and financial feasibility can be demonstrated. Expenditure incurred during the year was £606,368 (2023: £405,454).
Judgements and key sources of estimation uncertainty
In the application of the group's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods . Key sources of estimation uncertainty The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows. Carrying value of Goodwill Conexpo (NI) Limited acquired Miskelly Brothers Limited in 2015. The company was purchased at a cost lower than the fair value of the net assets acquired. This created the negative goodwill balance in the financial statements shown separately on the balance sheet. The negative goodwill has been estimated as having an expected life of 9 years. The group continues to monitor the carrying value of this negative goodwill using judgements based on the future cashflows expected to be generated and the benefits acquired .
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Land and Buildings | - | 2 - 16.66% Straight Line
| Plant and machinery | - | 6.67 - 20% Straight Line
| Fixtures and fittings | - | 33% straight line
| Motor vehicles | - | 20% straight line

Freehold land is not depreciated.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Turnover
Turnover arises from:

| 2024 | 2023
| £ | £
Sale of goods | 38,907,620 | 36,623,885
| ------------- | -------------

The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
5. Other operating income

| 2024 | 2023
| £ | £
Government grant income | 1,418 | 1,294
Other operating income | 418,506 | 429,036
| --------- | ---------
| 419,924 | 430,330
| --------- | ---------

6. Operating profit
Operating profit or loss is stated after charging/crediting:

| 2024 | 2023
| £ | £
Depreciation of tangible assets | 847,636 | 767,549
Gains on disposal of tangible assets | ( 56,000) | ( 2,093)
Foreign exchange differences | – | 1,303
| --------- | ---------

7. Auditor's remuneration

| 2024 | 2023
| £ | £
Fees payable for the audit of the financial statements | 17,500 | 15,000
| -------- | --------

Fees payable to the company's auditor and its associates for other services:

Other non-audit services | 7,000 | 5,000
| -------- | --------

8. Staff costs
The average number of persons employed by the company during the year, including the directors, amounted to:

| 2024 | 2023
| No. | No.
Production staff | 34 | 31
Distribution staff | 8 | 8
| ---- | ----
| 42 | 39
| ---- | ----

The aggregate payroll costs incurred during the year, relating to the above, were:

| 2024 | 2023
| £ | £
Wages and salaries | 2,018,000 | 2,032,264
Social security costs | 215,682 | 228,003
Other pension costs | 62,420 | 55,082
| ------------ | ------------
| 2,296,102 | 2,315,349
| ------------ | ------------

9. Directors' remuneration
The directors' aggregate remuneration in respect of qualifying services was:

| 2024 | 2023
| £ | £
Remuneration | 242,568 | 330,067
Company contributions to defined contribution pension plans | 8,400 | 8,400
| --------- | ---------
| 250,968 | 338,467
| --------- | ---------

The number of directors who accrued benefits under company pension plans was as follows:

| 2024 | 2023
| No. | No.
Defined contribution plans | 2 | 2
| ---- | ----

Remuneration of the highest paid director in respect of qualifying services:

| 2024 | 2023
| £ | £
Aggregate remuneration | 135,000 | 78,784
| --------- | --------

10. Other interest receivable and similar income

| 2024 | 2023
| £ | £
Interest on cash and cash equivalents | 234,277 | 178,421
| --------- | ---------

11. Interest payable and similar expenses

| 2024 | 2023
| £ | £
Interest on banks loans and overdrafts | 26,737 | 304,875
| -------- | ---------

12. Tax on profit
Major components of tax expense

| 2024 | 2023
| £ | £

Current tax:

UK current tax expense | 1,362,415 | 1,145,721
Adjustments in respect of prior periods | 404 | 11,857
| ------------ | ------------
Total current tax | 1,362,819 | 1,157,578
| ------------ | ------------

Deferred tax:

Origination and reversal of timing differences | 509,931 | ( 82,855)
| ------------ | ------------
Tax on profit | 1,872,750 | 1,074,723
| ------------ | ------------

Reconciliation of tax expense
The tax assessed on the profit on ordinary activities for the year is higher than (2023: lower than) the standard rate of corporation tax in the UK of 25 % (2023: 25 %).

| 2024 | 2023
| £ | £
Profit on ordinary activities before taxation | 6,989,312 | 5,787,534
| ------------ | ------------
Profit on ordinary activities by rate of tax | 1,747,328 | 1,446,885
Adjustment to tax charge in respect of prior periods | 404 | 11,857
Effect of expenses not deductible for tax purposes | ( 4,130) | 9,200
Effect of capital allowances and depreciation | ( 250,414) | ( 140,003)
Effect of different UK tax rates on some earnings | – | (72,066)
Research and development credit | ( 130,369) | ( 98,295)
Origination and reversal of timing differences | 509,931 | ( 82,855)
| ------------ | ------------
Tax on profit | 1,872,750 | 1,074,723
| ------------ | ------------

13. Dividends

| 2024 | 2023
| £ | £
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year ) | 1,868,807 | 999,963
| ------------ | ---------

14. Tangible assets

| Land and Buildings | Plant and machinery | Fixtures and fittings | Motor vehicles | Total
| £ | £ | £ | £ | £
Cost |  |  |  |  |
At 1 January 2024 | 11,764,098 | 12,883,798 | 100,309 | 507,364 | 25,255,569
Additions | – | 1,486,900 | – | – | 1,486,900
Disposals | – | ( 325,000) | – | – | ( 325,000)
| ------------- | ------------- | --------- | --------- | -------------
At 31 December 2024 | 11,764,098 | 14,045,698 | 100,309 | 507,364 | 26,417,469
| ------------- | ------------- | --------- | --------- | -------------
Depreciation |  |  |  |  |
At 1 January 2024 | 230,277 | 8,592,109 | 100,079 | 142,541 | 9,065,006
Charge for the year | 13,872 | 740,787 | 132 | 92,845 | 847,636
Disposals | – | ( 325,000) | – | – | ( 325,000)
| ------------- | ------------- | --------- | --------- | -------------
At 31 December 2024 | 244,149 | 9,007,896 | 100,211 | 235,386 | 9,587,642
| ------------- | ------------- | --------- | --------- | -------------
Carrying amount |  |  |  |  |
At 31 December 2024 | 11,519,949 | 5,037,802 | 98 | 271,978 | 16,829,827
| ------------- | ------------- | --------- | --------- | -------------
At 31 December 2023 | 11,533,821 | 4,291,689 | 230 | 364,823 | 16,190,563
| ------------- | ------------- | --------- | --------- | -------------

Included within the carrying value of land and buildings is long leasehold with a carrying value of £1,223,040 (2023: £1,223,040).
15. Investments

| Shares in group undertakings
| £
Cost |
At 1 January 2024 and 31 December 2024 | 11,473,155
| -------------
Impairment |
At 1 January 2024 and 31 December 2024 | –
| -------------

Carrying amount |
At 31 December 2024 | 11,473,155
| -------------
At 31 December 2023 | 11,473,155
| -------------

Subsidiaries, associates and other investments

| Registered office | Class of share | Percentage of shares held
Subsidiary undertakings |  |  |
Miskelly Brothers Limited | Aisling House | Ordinary | 100
| 50 Stranmillis Embankment |  |
| Belfast |  |
| BT9 5FL |  |

16. Stocks

| 2024 | 2023
| £ | £
Finished goods and goods for resale | 1,051,630 | 961,669
| ------------ | ---------

17. Debtors

| 2024 | 2023
| £ | £
Trade debtors | 2,900,668 | 4,304,482
Prepayments and accrued income | 352,168 | 838,112
Other debtors | 44,949 | 13,144
| ------------ | ------------
| 3,297,785 | 5,155,738
| ------------ | ------------

18. Creditors: amounts falling due within one year

| 2024 | 2023
| £ | £
Bank loans and overdrafts | – | 531,149
Trade creditors | 2,559,733 | 3,553,963
Amounts owed to group undertakings | 4,954,391 | 5,404,663
Accruals and deferred income | 54,362 | 30,700
Corporation tax | 582,274 | 616,193
Social security and other taxes | 761,208 | 682,791
Director loan accounts | 696,000 | 248,846
Other creditors | 162,191 | 235,401
| ------------ | -------------
| 9,770,159 | 11,303,706
| ------------ | -------------

19. Creditors: amounts falling due after more than one year

| 2024 | 2023
| £ | £
Bank loans and overdrafts | – | 1,200,404
| ---- | ------------

20. Provisions

| Deferred tax (note 21)
| £
At 1 January 2024 | 2,069,905
Additions | 509,931
| ------------
At 31 December 2024 | 2,579,836
| ------------

21. Deferred tax
The deferred tax included in the statement of financial position is as follows:

| 2024 | 2023
| £ | £
Included in provisions (note 20) | 2,579,836 | 2,069,905
| ------------ | ------------

The deferred tax account consists of the tax effect of timing differences in respect of:

| 2024 | 2023
| £ | £
Accelerated capital allowances | 2,579,836 | 2,069,905
| ------------ | ------------

22. Employee benefits
Defined contribution plans
The amount recognised in profit or loss as an expense in relation to defined contribution plans was £ 62,420 (2023: £ 55,082 ).
23. Government grants
The amounts recognised in the financial statements for government grants are as follows:

| 2024 | 2023
| £ | £

Recognised in other operating income:

Government grants recognised directly in income | 1,418 | 1,294
| ------- | -------

24. Called up share capital
Issued, called up and fully paid

| 2024 | 2023
| No. | £ | No. | £
Ordinary shares of £ 1 each | 66,670 | 66,670 | 66,670 | 66,670
| -------- | -------- | -------- | --------

25. Reserves
Capital redemption reserve - This reserve records the nominal value of shares repurchased by the company. Profit and loss account - This reserve records retained earnings and accumulated losses.
26. Guarantees
A floating charge covering all monies the undertaking of the company and all its property whatsoever and wheresoever both present and future including its uncalled share capital for the time being.
There is an unlimited intercompany cross company guarantee between Conexpo (NI) Limited and Miskelly Brothers Limited.
27. Analysis of changes in net debt

| At 1 Jan 2024 | Cash flows | At 31 Dec 2024
| £ | £ | £
Cash at bank and in hand | 6,256,519 | 2,152,463 | 8,408,982
Debt due within one year | (6,184,658) | 534,267 | (5,650,391)
Debt due after one year | (1,200,404) | 1,200,404 | –
| ------------ | ------------ | ------------
| ( 1,128,543) | 3,887,134 | 2,758,591
| ------------ | ------------ | ------------

28. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:

| 2024 | 2023
| £ | £
Not later than 1 year | 112,500 | 112,500
Later than 1 year and not later than 5 years | 328,125 | 440,625
| --------- | ---------
| 440,625 | 553,125
| --------- | ---------

29. Directors' advances, credits and guarantees
Dividends totalling £1,868,807 (2023: £999,963) were paid in the year in respect of shares held by the company's directors. The amounts owing to the directors at 31 December 2024 is £696,000 (2023 £248,846).
30. Related party transactions
Remuneration of key management personnel The remuneration of the key management personnel of the group, who are also directors, is shown in Note 9. The company has taken advantage of the exemption from disclosing related party transactions with group companies, in accordance with FRS 102 "The Financial Reporting Standard applicable to the UK and the Republic of Ireland", Section 33 Related Party Disclosures.

Conexpo (NI) Limited

Notes to the Financial Statements (continued)

Year ended 31 December 2024
31. Controlling party
The company is a wholly owned subsidiary of Josten Ltd , a company incorporated in Northern Ireland. The ultimate controlling parties are Mr J McCluskey and Mr S McCluskey . The group is controlled by its directors, Mr R McCluskey , Mrs B McCluskey , Mr J McCluskey, and Mr S McCluskey. Copies of the consolidated financial statements for Josten Ltd may be obtained from Aisling House, 50 Stranmillis Embankment, Belfast, BT9 5FL .